UNICREDIT BANK/CALL/MERCK/200/0.1/18.12.24 Stock

Warrant

DE000HC30WC3

Market Closed - BOERSE MUENCHEN 03:41:21 2024-05-24 pm EDT
0.42 EUR -6.67% Intraday chart for UNICREDIT BANK/CALL/MERCK/200/0.1/18.12.24
Current month+180.00%
1 month+133.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 0.42 -6.67%
24-05-23 0.45 +9.76%
24-05-22 0.41 +20.59%
24-05-21 0.34 0.00%
24-05-20 0.34 -10.53%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 03:41 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HC30WC
ISINDE000HC30WC3
Date issued 2023-01-11
Strike 200
Maturity 2024-12-18 (207 Days)
Parity 10 : 1
Emission price 3.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.54
Lowest since issue 0.14
Spread 0.05
Spread %11.11%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.8 EUR
Average target price
182.9 EUR
Spread / Average Target
+9.05%
Consensus